BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33252027)

  • 1. Effectiveness of ursodeoxycholic acid treatment in the prevention of gallstone formation after laparoscopic sleeve gastrectomy.
    Alimoğulları M; Buluş H
    Acta Chir Belg; 2021 Apr; 121(2):109-114. PubMed ID: 33252027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
    Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
    Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid for prevention of gallstone disease after laparoscopic sleeve gastrectomy: an Atlantic Canada perspective.
    Hossain I; Brodie J; O'Brien E; Tedman-Aucoin K; Lawlor D; Murphy R; Twells L; Pace D; Evans B; Ellsmere J
    Surg Endosc; 2023 Jul; 37(7):5236-5240. PubMed ID: 36952047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
    Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
    BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy.
    Adams LB; Chang C; Pope J; Kim Y; Liu P; Yates A
    Obes Surg; 2016 May; 26(5):990-4. PubMed ID: 26342481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholelithiasis After Sleeve Gastrectomy and Effectiveness of Ursodeoxycholic Acid Treatment.
    Şen O; Türkçapar AG; Yerdel MA
    J Laparoendosc Adv Surg Tech A; 2020 Nov; 30(11):1150-1152. PubMed ID: 32228343
    [No Abstract]   [Full Text] [Related]  

  • 7. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
    Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid for the prevention of gall stones after laparoscopic sleeve gastrectomy: a prospective controlled study.
    Salman MA; Salman A; Mohamed US; Hussein AM; Ameen MA; Omar HSE; Elewa A; Hamdy A; Elias AA; Tourky M; Helal A; Mahmoud AA; Aljarad F; Moustafa A; Shaaban HE; Nashaat A; Hussein AM; Omar T; Balamoun H
    Surg Endosc; 2022 Sep; 36(9):6396-6402. PubMed ID: 35020052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ursodeoxycholic acid in the prevention of gallstone formation after laparoscopic sleeve gastrectomy.
    Abdallah E; Emile SH; Elfeki H; Fikry M; Abdelshafy M; Elshobaky A; Elgendy H; Thabet W; Youssef M; Elghadban H; Lotfy A
    Surg Today; 2017 Jul; 47(7):844-850. PubMed ID: 27837275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial).
    Haal S; Guman MSS; de Brauw LM; van Veen RN; Schouten R; Fockens P; Gerdes VEA; Dijkgraaf MGW; Voermans RP
    Trials; 2020 Jul; 21(1):676. PubMed ID: 32703246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial.
    Lee SH; Jang DK; Yoo MW; Hwang SH; Ryu SY; Kwon OK; Hur H; Man Yoon H; Eom BW; Ahn HS; Son T; Song KY; Lee HH; Choi MG; An JY; Lee SI; Lee KH; Ahn S; Park YS; Park DJ;
    JAMA Surg; 2020 Aug; 155(8):703-711. PubMed ID: 32584935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Anti-Helicobacter pylori Antibody Seropositive and De Novo Gallstone Formation After Laparoscopic Sleeve Gastrectomy for Japanese Patients with Severe Obesity.
    Hashimoto K; Nagao Y; Nambara S; Tsuda Y; Kudou K; Kusumoto E; Sakaguchi Y; Kusumoto T; Ikejiri K
    Obes Surg; 2022 Oct; 32(10):3404-3409. PubMed ID: 36006591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones.
    Della Penna A; Lange J; Hilbert J; Archid R; Königsrainer A; Quante M
    Obes Surg; 2019 Apr; 29(4):1216-1221. PubMed ID: 30604076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ursodeoxycholic acid on gallstone formation after bariatric surgery: An updated meta-analysis.
    Ying J; Dai S; Fu R; Hong J; Dai C; Jin Q
    Obesity (Silver Spring); 2022 Jun; 30(6):1170-1180. PubMed ID: 35475596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral ursodeoxycholic acid on cholelithiasis following laparoscopic sleeve gastrectomy for morbid obesity.
    Nabil TM; Khalil AH; Gamal K
    Surg Obes Relat Dis; 2019 Jun; 15(6):827-831. PubMed ID: 31113752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of cholelithiasis after sleeve gastrectomy and its association with weight loss: A two-centre retrospective cohort study.
    Manatsathit W; Leelasinjaroen P; Al-Hamid H; Szpunar S; Hawasli A
    Int J Surg; 2016 Jun; 30():13-8. PubMed ID: 27063855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis.
    Magouliotis DE; Tasiopoulou VS; Svokos AA; Svokos KA; Chatedaki C; Sioka E; Zacharoulis D
    Obes Surg; 2017 Nov; 27(11):3021-3030. PubMed ID: 28889240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery.
    Haal S; Guman MSS; de Brauw LM; Schouten R; van Veen RN; Fockens P; Gerdes VEA; Voermans RP; Dijkgraaf MGW
    Br J Surg; 2022 Oct; 109(11):1116-1123. PubMed ID: 35979609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased gallstone formation after sleeve gastrectomy and the preventive role of ursodeoxycholic acid.
    Vural A; Goksu K; Kahraman AN; Boy FN; Anil BS; Fersahoglu MM
    Acta Gastroenterol Belg; 2020; 83(1):33-38. PubMed ID: 32233269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Factors of Cholelithiasis After Prophylactic Administration of Ursodeoxycholic Acid Following Laparoscopic Bariatric Surgery: Tehran Obesity Treatment Study.
    Barzin M; Andalib A; Khalaj A; Mahdavi M; Valizadeh M; Mousapour P; Hosseinpanah F
    Obes Surg; 2022 Feb; 32(2):311-317. PubMed ID: 34816356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.